Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Capra Biosciences logo — Harnessing biology for efficient and low-carbon production o...

Capra Biosciences

Harnessing biology for efficient and low-carbon production of everyday chemicals

Founded 2020 United States Manassas, United States 15 employees Grant Total: $12.70M Biotechnology, Life Sciences

General Information

Company Name Capra Biosciences
Founded Year 2020
Location United States Manassas, United States +1
Employees 15
Industries Biotechnology, Life Sciences
Funding Stage Grant
Social

Get notified when Capra Biosciences moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Capra Biosciences

Capra Biosciences, a biotechnology startup based in the United States, was founded in 2020. The company's slogan "Harnessing biology for efficient and low-carbon production of everyday chemicals" reflects its commitment to developing a new technology that will revolutionize the manufacturing of chemicals using biology. Despite significant advancements in synthetic biology over the past 20 years, the cost-competitive large-scale manufacturing of these products has remained a significant bottleneck. However, Capra Biosciences aims to address this challenge through its innovative bioreactor design, which promises to significantly reduce end-to-end manufacturing costs. The company recently secured a $3.40M Seed Round investment on 12 December 2023, signaling investor confidence in its technology and business model. Capra Biosciences' focus on sustainability and cost-efficiency aligns with the growing demand for environmentally friendly alternatives to petrochemical products. With the potential to improve both environmental impact and performance, the technology developed by Capra Biosciences holds promise for disrupting the chemical manufacturing industry. As the startup continues to progress, its innovative approach and emphasis on addressing critical industry challenges position it as an intriguing investment opportunity within the biotechnology sector.

Taxonomy: synthetic biology, bioreactor design, chemical manufacturing, biosynthesis, petrochemical alternatives, sustainable production, low-carbon, biomolecular engineering

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1 •••• •••• 19 Jul 2024
Seed Round •••••• - 12 Dec 2023
Pre Seed Round •••••• 9
Investor Investor Investor Investor Investor Investor
•••• •••• 		06 Jun 2022
Convertible Note •••••• 2
Investor Investor
18 Jan 2022
Convertible Note •••••• 1
Investor
03 Jun 2021

View All 6 Funding Rounds

Capra Biosciences Alternatives & Competitors

Capra Biosciences vs
Airborne
Airborne The Netherlands

Shaping the composites value chain for a sustainable tomorrow

Unknown
233 employees
Capra Biosciences vs
SynHelix
SynHelix France

Demand for synthetic DNA is growing rapidly in biotech industry, and SynHelix aims to meet supply ne...

11-50 employees
Biotechnology
Capra Biosciences vs
Embedded IT Solutions (India) Private Limited (EIS)
Embedded IT Solutions (India) Private Limited (EIS) India

EIS is a recognized Electronic Manufacturing Service (EMS) provider with state of the art facilities...

106 employees
Industrial, Manufacturing

FAQ About Capra Biosciences

Harnessing biology for efficient and low-carbon production of everyday chemicals
Capra Biosciences was founded in 2020.
Capra Biosciences is headquartered in Manassas, United States.
Capra Biosciences operates in the following industries: Biotechnology, Life Sciences.
Capra Biosciences has approximately 15 employees.
Capra Biosciences has completed 6 funding rounds, raising a total of $12.70M. The latest funding stage is Grant.
Top alternatives and competitors to Capra Biosciences include Airborne, SynHelix, Embedded IT Solutions (India) Private Limited (EIS), Elcam Medical, TestGrid.io. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Capra Biosciences and Airborne are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Capra Biosciences and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy